- Home
- ORMP vs MSD Comparison
ORMP vs MSD Comparison
Compare ORMP & MSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORMP | MSD |
|---|---|---|
| Founded | 2002 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.3M | 147.5M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | ORMP | MSD |
|---|---|---|
| Price | $4.32 | $7.34 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 171.6K | 64.8K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | 6.51% | ★ 11.26% |
| EPS Growth | ★ 412.50 | N/A |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $2,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.90 | ★ N/A |
| Revenue Growth | ★ 49.25 | N/A |
| 52 Week Low | $1.98 | $6.91 |
| 52 Week High | $5.19 | $7.94 |
Technical Indicators
Market Signals| Indicator | ORMP | MSD |
|---|---|---|
| Relative Strength Index (RSI) | 57.66 | 54.22 |
| Support Level | $3.90 | $7.23 |
| Resistance Level | $5.10 | $7.43 |
| Average True Range (ATR) | 0.18 | 0.06 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 79.24 | 78.64 |
Price Performance
Historical ComparisonAbout ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
About MSD Morgan Stanley Emerging Markets Debt Fund Inc.
Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.